Home / Media Centre / Company News / CARDIOPROTECTIVE AGENT CRATAL: 10 YEARS OF VICTORIES OVER CARDIAC DISORDERS

28.02.2013
February 27: The on-line press conference "How can we hear our heart?" was held. Medical experts, representatives of Borshchahivskiy Chemical and Pharmaceutical Plant and mass-media participated in this press conference.
Leading doctors of the industry and a representative of the manufacturer, PhD Galina A. Kutsyna answered questions of readers and journalists. It was only too natural that the press conference focused on Cratal.
Cratal is a natural medicinal product, which has been winning recognition from both doctors and patients for over 10 years. Cratal is unique by its multiple therapeutic actions, which is provided by its components: extracts of hawthorn and motherwort in combination with the amino acid taurine. The formula of this product was developed 20 years ago and since then its effectiveness has not been questioned. For example, Cratal is successfully used for the treatment of patients with cardiovascular diseases; it is used in a single agent therapy to treat patients with vegetovascular dysfunction, increased fatigue, and nervousness.
The representatives of Borshchahivskiy Chemical and Pharmaceutical Plant also announced a new form of the Cratal, "Cratal for children", which will soon be put on the market
-
11.11.2013
PJSC SIC “BORSHCHAHIVSKIY CPP” PARTICIPATED IN CPHI WORLDWIDE 2013
-
11.09.2013
PJSC SIC “BORSHCHAHIVSKIY” PARTICIPATED IN THE EXHIBITION CPHI SOUTH AMERICA 2013, SAO PAULO, BRAZILPJSC SIC “BORSHCHAHIVSKIY” PARTICIPATED IN THE EXHIBITION CPHI SOUTH AMERICA 2013, SAO PAULO, BRAZIL
-
17.07.2013
PJSC SIC 'BCPP' LAUNCHED THE NEW SEDATIVE/SLEEPING AGENT VALERICA